Search Results - "Fiset, P. O."

Refine Results
  1. 1

    Syphilis-related rapidly progressive glomerulonephritis: a case presentation by Qi, A, Fiset, P O, Pilozzi-Edmonds, L

    Published in BMC nephrology (25-05-2021)
    “…Syphilis is a multisystemic infection that causes a wide variety of symptoms and thus has been dubbed one of the great medical mimickers. Due to recent global…”
    Get full text
    Journal Article
  2. 2

    Children with atopic histories exhibit impaired lipopolysaccharide-induced Toll-like receptor-4 signalling in peripheral monocytes by Préfontaine, D., Banville-Langelier, A.-A., Fiset, P.-O., Guay, J., An, J., Mazer, M., Hamid, Q., Mazer, B. D.

    Published in Clinical and experimental allergy (01-11-2010)
    “…Summary Background The hygiene hypothesis states that early exposure to bacterial products such as lipopolysaccharide (LPS) may be protective against the…”
    Get full text
    Journal Article
  3. 3

    Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer by Wang, H., Agulnik, J., Kasymjanova, G., Wang, A., Jiménez, P., Cohen, V., Small, D., Pepe, C., Sakr, L., Fiset, P.O., Auger, M., Camilleri-Broet, S., Alam El Din, M., Chong, G., van Kempen, L., Spatz, A.

    Published in Annals of oncology (01-06-2018)
    “…PD-L1 immunohistochemistry (IHC) testing is usually carried out on tissue blocks from core needle biopsy or surgical resections. In this study, we assessed the…”
    Get full text
    Journal Article
  4. 4

    Signal transducer and activator of transcription 6 down-regulates toll-like receptor-4 expression of a monocytic cell line by Fiset, P. O., Tulic, M. K., Skrablin, P. S. A., Grover, S. M., Létuvé, S., Mazer, B. D., Hamid, Q.

    Published in Clinical and experimental allergy (01-02-2006)
    “…Summary Background Toll‐like receptor 4 (TLR4), part of the bacterial lipopolysaccharide (LPS) receptor, is an important bridge between innate and adaptive…”
    Get full text
    Journal Article
  5. 5

    The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma by Wang, H., Agulnik, J., Kasymjanova, G., Fiset, P.O., Camilleri-Broet, S., Redpath, M., Cohen, V., Small, D., Pepe, C., Sakr, L., Spatz, A.

    Published in Lung cancer (Amsterdam, Netherlands) (01-06-2019)
    “…•The PD-L1 expression similar in NSCLC from distant metastatic sites.•Samples from any accessible distant metastatic sites can be used for PD-L1 testing.•The…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Amb a 1–immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response by Tulic, Meri K, Fiset, Pierre-Olivier, Christodoulopoulos, Pota, Vaillancourt, Patrice, Desrosiers, Martin, Lavigne, François, Eiden, Joseph, Hamid, Qutayba

    Published in Journal of allergy and clinical immunology (01-02-2004)
    “…Amb a 1–immunostimulatory phosphorothioate oligonucleotide conjugate (AIC) is a novel immunotherapeutic compound consisting of purified Amb a 1 from short…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Modulation of allergic response in nasal mucosa by antisense oligodeoxynucleotides for IL-4 by Fiset, Pierre-Olivier, Soussi-Gounni, Abdelilah, Christodoulopoulos, Pota, Tulic, Meri, Sobol, Steven E., Frenkiel, Saul, Lavigne, François, Lamkhioued, Bouchaib, Hamid, Qutayba

    Published in Journal of allergy and clinical immunology (01-03-2003)
    “…Background: The cytokine IL-4 is highly involved in TH2 inflammation, such as that seen in allergic rhinitis. IL-4 can induce IgE synthesis and eotaxin. Recent…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    776P - Interim analysis of a phase II trial of perioperative chemotherapy plus avelumab in esophagogastric and gastric adenocarcinoma by Alcindor, T., Opu, T., Mueller, C., Marcus, V., Fiset, P.-O., Camilleri-Broet, S., Artho, G., Asselah, J., Vanhuyse, M., Hickeson, M., Awan, A., Koulouris, Z., Ferri, L.

    Published in Annals of oncology (01-10-2019)
    “…Perioperative chemotherapy improves cure rate in locally advanced esophagogastric and gastric adenocarcinoma. Immunotherapy is active at the metastatic stage…”
    Get full text
    Journal Article
  15. 15

    776PInterim analysis of a phase II trial of perioperative chemotherapy plus avelumab in esophagogastric and gastric adenocarcinoma by Alcindor, T, Opu, T, Mueller, C, Marcus, V, Fiset, P-O, Camilleri-Broet, S, Artho, G, Asselah, J, Vanhuyse, M, Hickeson, M, Awan, A, Koulouris, Z, Ferri, L

    Published in Annals of oncology (01-10-2019)
    “…Abstract Background Perioperative chemotherapy improves cure rate in locally advanced esophagogastric and gastric adenocarcinoma. Immunotherapy is active at…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    IL-17E upregulates the expression of proinflammatory cytokines in lung flbroblasts by Letuve, S, Lajoie-Kadoch, S, Audusseau, S, Rothenberg, ME, Fiset, P-O, Ludwig, MS, Hamid, Q

    Published in Journal of Allergy and Clinical Immunology (01-03-2006)
    “…Background IL-17E is a new T sub(H)2 cytokine that promotes airway eosinophilia in mice. IL-17E proinflammatory activity has been proposed to involve induction…”
    Get full text
    Journal Article